BRIEF published on 12/27/2024 at 07:35, 1 year 1 month ago Sensorion finalise le recrutement pour l'essai de phase 1/2 d'Audiogene Thérapie Génique Sensorion Perte Auditive SENS-501 Essai Audiogene
PRESS RELEASE published on 12/27/2024 at 07:30, 1 year 1 month ago Inside Information / Other news releases Sensorion completes enrollment of the first cohort in the Audiogene Phase 1/2 gene therapy clinical trial, targeting infants with hearing loss disorders Gene Therapy Clinical Trial Sensorion Hearing Loss Disorders Audiogene
BRIEF published on 12/18/2024 at 07:35, 1 year 1 month ago Sensorion présente des résultats préliminaires positifs pour le SENS-501 Essai Clinique Thérapie Génique Innovation Biotechnologique SENS-501 Surdité Congénitale
BRIEF published on 12/18/2024 at 07:35, 1 year 1 month ago Sensorion Reports Positive Preliminary Results for SENS-501 Gene Therapy Clinical Trial SENS-501 Congenital Deafness Biotechnological Innovation
PRESS RELEASE published on 12/18/2024 at 07:30, 1 year 1 month ago Informations privilégiées / Autres communiqués Sensorion présente des données positives de l'essai clinique de Phase 1/2 de thérapie génique pour la surdité chez les nourrissons. Nouvelles données encourageantes sur SENS-501. Séminaire en ligne prévu pour 2025 Sécurité Thérapie Génique Phase 1/2 Sensorion Surdité
PRESS RELEASE published on 12/18/2024 at 07:30, 1 year 1 month ago Inside Information / Other news releases Sensorion reports positive safety data and behavioral changes in toddlers from the Audiogene Phase 1/2 Gene Therapy Clinical Trial. Plans KOL event in 2025 for further discussion Gene Therapy Clinical Trial Sensorion Hearing Loss Audiogene
BRIEF published on 11/06/2024 at 07:35, 1 year 2 months ago Sensorion to Join Key Investor Conferences in November 2024 Biotechnology Investor Conferences Sensorion Hearing Loss Therapies Gene Therapy Development
BRIEF published on 11/06/2024 at 07:35, 1 year 2 months ago Sensorion participera aux principales conférences d'investisseurs en novembre 2024 Biotechnologie Conférences D'investisseurs Sensorion Thérapies Pour La Perte Auditive Développement De La Thérapie Génique
PRESS RELEASE published on 11/06/2024 at 07:30, 1 year 2 months ago Inside Information / Other news releases Sensorion to participate in upcoming investor conferences in November 2024, including Stifel Healthcare Conference and LifeSci Capital & Sofinnova Partners Summit Biotechnology Investor Conferences Clinical-stage Sensorion Hearing Loss Disorders
PRESS RELEASE published on 11/06/2024 at 07:30, 1 year 2 months ago Informations privilégiées / Autres communiqués Sensorion annonce sa participation à plusieurs conférences investisseurs en novembre 2024. Découvrez les événements à venir et les programmes de thérapie de l'entreprise Biotechnologie Conférences Investisseurs Événements Sensorion Thérapies Auditives
Published on 02/02/2026 at 00:05, 3 hours 22 minutes ago Resource Upgrade Drilling Begins on Challenger Open Pits
Published on 01/31/2026 at 03:15, 2 days ago Empress Royalty Announces Grant Of Restricted Share Units
Published on 01/31/2026 at 01:40, 2 days 1 hour ago Star Copper Announces Grant of RSUs, Stock Options and PSUs
Published on 02/02/2026 at 02:50, 37 minutes ago Xinhua Silk Road: Ecosystem and sustainability redefine global automotive brand value: report
Published on 02/01/2026 at 20:25, 7 hours 2 minutes ago WHO Makes Historic Pivot to County-Level Governance, Validating "Bottom-Up" Climate-Health Model in Tropical Southern China
Published on 01/31/2026 at 15:54, 1 day 11 hours ago EQS-Adhoc: Wolford AG: Capital increase will not be implemented
Published on 01/31/2026 at 12:25, 1 day 15 hours ago JOHNNIE WALKER TOASTS MUSIC'S BIGGEST WEEKEND WITH THE GO GO HIGHBALL
Published on 01/30/2026 at 18:40, 2 days 8 hours ago ICADE - Bilan semestriel du contrat de liquidite
Published on 01/30/2026 at 17:45, 2 days 9 hours ago Schneider Electric launches a capital increase reserved for employees
Published on 01/30/2026 at 17:45, 2 days 9 hours ago Schneider Electric lance une augmentation de capital réservée aux salariés
Published on 01/30/2026 at 08:30, 2 days 18 hours ago Claude Bernard lance Senior+, un assistant IA conçu pour améliorer la prise en charge des patients les plus âgés
